DNDN

Upgraded Biotech Flashes Short-Term Buy Signal

Dendreon's 20-day moving average recently crossed up through its 200-day moving average. Get the target for DNDN. More 

Surprise! Dendreon Doesn’t Stink Anymore

It took three years, but this biotech may be quietly finding its footing as its innovative Provenge prostate-cancer fighter gains credibility. More 

S&P Hits Five-Year High — Thursday’s IP Market Recap

Positive earnings news, big corporate headlines and solid China exports helped move markets north and launched the S&P to five-year highs. More 

Stocks Pop to Open 2013 — Wednesday’s IP Market Recap

A deal averting the fiscal cliff sent stocks on a large, broad rally, including a 30-for-30 day for the Dow Jones Industrial Average More 

Not Enough Spark From ‘Merger Monday’ — Monday’s IP Market Recap

Wall Street saw three big deals in the mergers & acquisition world Monday, but the markets mostly shrugged with a flat performance. More 

Nothing Left to Do but Vote — Monday’s IP Market Recap

Stocks traded slightly higher on the day, led mostly by a rise in Apple, though many investors shied off big moves before tomorrow's presidential election. More 

Inflation and Stocks Stay Flat: Wednesday’s IP Market Recap

Retail stocks continued to flourish as markets moved around during the day before ending mixed More